Open Access Open Access  Restricted Access Subscription or Fee Access

A Study on “KAP [Knowledge, Attitude and Practice] Study on Successful Prevention and Control of COVID-19 Outbreaks Among Public: A Community Based Health Related Project”

Mekkanti Manasa Rekha, Mohammed Zubair, Rinku Mathappan


Objective: To assess knowledge, attitude, & practice of RT Nagar residents towards corona virus Disease 2019 (COVID-19). Methods: A self-designed questionnaire was developed and given to residents. The demographics mean knowledge, attitude, and practice of the participants were investigated; the scores were calculated. T-test & ANOVA were used for statistical analysis. Results: Out of the total participants (n = 354), 50.3% were male and 54.5% were 21015023 yrs. Almost. All the participants (96.6%) had the frequency of washing hands under the influence of COVID-19. Although no significant relationship was found b/w different religions, age-categories In terms of knowledge, participants who were aged 21–23 years had higher knowledge. In addition, gender had significant impact on practice scores (P<0.05) while no demographic Variable was found to have a significant relation with attitude score (P>0.05). Conclusions: The majority of the participants had good knowledge, positive attitude, Sufficient Practice. Females and males have significantly different practices. Although the results are Very positive, it is suggested that people should continue to strengthen knowledge, attitude, and Practice towards COVID-19, So that India can win the battle against the disease. The KAP survey can identify a lack of knowledge, operating procedures or Cultural beliefs, Thereby enhancing the understanding of the disease. KAP survey can highlight factors which influence “bad” behaviour, the reasons behind certain Attitudes & the reasons and methods behind certain practices towards COVID-19.


COVID-19, Noval coronavirus, Knowledge, Attitude, Practice, Social distancing, Lockdown

Full Text:



Andersen KG, Rambaut A, Lipkin WI et al. (2020) the proximal origin of SARS-CoV-2. Nat Med. 2020 Apr; 26 (4): 450–452.

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020 Jan 28; 9 (1): 221–236.

Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res. 2020 Apr; 176: 104742.

Shazia tabassum, et al. The Pathophysiology of Virulence of the COVID-19 Virus. Preprints ( Posted: 7 April 2020.

Y. Pan, X. Li, G. Yang, J. Fan, Y. Tang, J. Zhao, X. Long, S. Guo, Z. Zhao, Y. Liu, H. Hu, H. Xue, Y. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020 Jul; 81 (1): e28–e32.

J. Zhang, J. Liu, N. Li, Y. Liu, R. Ye, X. Qin, R. Zheng Serological Detection of 2019-nCoV Respond to the Epidemic: A Useful Complement to Nucleic Acid Testing, Int Immunopharmacol. 2020 Nov; 88: 106861.

Larsen, joseph, modelling the onset of symptoms of COVID-19. Front Public Health. 2020 Aug 13; 8: 473.

RAMZY A, Mc Neil DG W.H.O declares global emergency as Wuhan coronavirus spreads. Available online at:

Tanu Singhal. The Novel Corona Virus/COVID-19–An Update. The Indian practitioner. 2020: 73 (3).

Arina anis azlan, et al.: Public-knowledge, attitudes and practices towards COVID-19: A cross sectional study in Malaysia. PLoS One. 2020 May 21; 15 (5): e0233668.

Sonam maheshwan, et al. Knowledge, attitude and practices towards corona virus disease 2019 among medical students: cross-sectional study. 2020: 9 (3): 100–104.

WHO. Advice for the public: Coronavirus disease (COVID-19). (updated on 1 October 2021.). Available online at:

RAPS {Regulatory Affairs Professional Society}. COVID-19 vaccine tracker. News Articles > 2020 > 3. Available online at:

Mayo Clinic. COVID-19 treatment Plasma therapy. Available online at: https://www.mayoclinic.


Donald P. Tashkin. Nebulized Treatments and the Possible Risk of Coronavirus Transmission: Where Is the Evidence? Journal of the COPD Foundation. 2020: 7 (3): 136–138.

Mohammed M Alvi, et al. Pharmacological and non-pharmacological efforts at prevention, mitigation and treatment for covid. J Drug Target. Aug-Sep 2020; 28 (7–8): 742–754.

James M. Sanders, et al. Pharmacological treatments for COVID-19. JAMA. 2020; 323 (18): 1824–1836.

JAMES B COTRELL. Division of infectious diseases and geographic medicine, Department of medicine, University of Texas, Southern western Medical Centre. Molecular Diagnosis of COVID-19. Available online at:

Akalu, Yonas; Ayelign, et al. Knowledge, Attitude and Practice Towards COVID-19 Among Chronic Disease Patients at Addis Zemen Hospital, Northwest Ethiopia. Infect Drug Resist; 13: 1949–1960, 2020.

Tasnima Haque, et al. Knowledge, attitude and practices (KAP) towards COVID-19 and assessment of risks of infection by SARS-CoV-2 among the Bangladeshi population: An online cross sectional survey. Research Square. Available online at: https://www.researchsquare.


Bao-Liang Zhong, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020; 16 (10): 1745–1752.

medRxiv and bioRxiv. Sima Rugarabamu, et al. Knowledge, attitudes, and practices (KAP) towards COVID-19: A quick online cross-sectional survey among Tanzanian residents. Available online at:

Rimesh Pal, et al. Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey. Diabetes Res Clin Pract. 2020 Aug; 166: 108344.

News Medical Lifescience. Scientists reveal most likely order of COVID-19 symptoms. By Angela Betsaida B. Laguipo, BSN. Aug 16 2020. Available online at:

Mayo Clinic. Coronavirus disease 2019 (COVID-19). Available online at:

CDC: “Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)--United States, Weekly/March 27, 2020/69 (12); 343–346.

World Health Organization: “Coronavirus disease 2019 (COVID-19): Situation Report 46.”Available online at:


a. Cleveland Clinic: “Here’s the Damage Coronavirus (COVID-19) Can Do to Your Lungs.” March 20, 2020/Lung. Available online at:,doctors%20term%20diffuse%20alvelolar%20damage.

Wei Zhao, et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol. 2020 May; 214 (5): 1072–1077.

Shen M., Zhou Y., Ye J., Abdullah Al-Maskri A.A., Kang Y., Zeng S. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal. April 2020:10 (2): 97–101.

GAO W.J., Zheng K., Ke J., Li L.M. Advances on the asymptomatic infection of COVID-19. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jul 10; 41 (7): 990–993.

Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Dec; 588 (7836): E6.

Kai H., Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res. 2020 Jul; 43 (7): 648–654.

Hu Z.B., Ci C. Screening and management of asymptomatic infection of corona virus disease 2019 (COVID-19) Chin J Prev Med. 2020 May 6; 54 (5): 484–485.

Diagnosis of COVID-19: Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 Aug; 296 (2): E32–E40.

Treatment of COVID-19: Chen J., Ling Y., Xi X.H., Liu P., Li F., Li T. Efficacies of lopinavir/ritonavir in the treatment of novel coronavirus pneumonia (in Chinese) Chin J Infect Dis. 2020; 38 (2): 86–89. [Google Scholar]

H. Harapan, et al. Coronavirus disease 2019 (COVID-19): a literature review J. Infect. Public Health, 2020 May; 13 (5): 667–673.

A. NaserGhandi, S.F. Allameh, R. Saffarpour. All about COVID-19 in brief. New Microbes New Infect. 2020 May; 35: 100678.

Alfonso J Rodriguez-Morales, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. Mar-Apr 2020; 34: 101623.

Jieliang Chen. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses Microbes Infect.2020 Mar; 22 (2): 69–71.

R. Jalandra, A.K. Yadav, D. Verma, N. Dalal, M. Sharma, R. Singh, A.Kumar, P.R. Solanki. Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics. Biomed. Pharmacotherapy. 2020: 129: p. 110446

Cheryl Yi-Pin Lee, et al. Serological approaches for COVID-19: epidemiologic perspective on surveillance and control. Front. Immunology. 2020 Apr 24; 11:879.

"Christian Tidona, et al. Alphacoronavirus. The Springer Index of Viruses. 2011: 371–383.

Li, T., Liu, D., Yang, Y. et al. Phylogenetic supertree reveals detailed evolution of SARS-CoV-2. Sci Rep 10, 22366 (2020).–8.

Woo PC, Lau SK, Lam CS, Lau CC, Tsang AK, Lau JH, Bai R, Teng JL, Tsang CC, Wang M, Zheng BJ, Chan KH, Yuen KY (2012). "Discovery of seven novel Mammalian and avian coronaviruses in the genus delta coronavirus supports bat coronaviruses as the gene source of alpha coronavirus and beta coronavirus and avian coronaviruses as the gene source of gamma coronavirus and delta coronavirus". J Virol. 2012 Apr; 86 (7): 3995–4008.

World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, 20 March 2020. Available from:

Angelopoulos A, Pathak R, Varma R, Jordan MI. Identifying and Correcting Bias from Time-and Severity-Dependent Reporting Rates in the Estimation of the COVID-19 Case Fatality Rate. SSRN Electronic Journal. doi:10.2139/ssrn.3556644.

World Health Organization. The true death toll of COVID-19.


Adhikari SP, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9 (1):29.

Chen N, Zhou M, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223): 507–513. Doi: 10.1016/S0140-6736(20)30211-7.

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020 Apr 24; 368 (6489): 409–412.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020 Mar 13; 367 (6483): 1260–1263.

Walls AC, Park YJ, Tortorici MA, Wall a, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr 16; 181 (2): 281–292.e6.

Lu R, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020 Feb 22; 395 (10224): 565–574.

Kumar S, Maurya VK, Prasad AK et al. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). VirusDis. 2020: 31 (1):13–21.

Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015: 1282:1–23.

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9 (1): 221–236.

2020.1719902.ECollection 2020.

Lin Yu, Shanshan Wu, et al. Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform. Clin Chem. 2020 Apr 21: hvaa102.

CDC. Information for Clinicians on Investigational Therapeutics for Patients with COVID-19. Available online at:

World Health Organization (WHO). DRAFT landscape of COVID-19 candidate vaccines-20 April 2020. Available online at:

Abbink P, Lemckert AAC, Ewald BA, et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol. 2007; 81(9): 4654–4663

Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020; 19 (5): 305–306.

Horby P, et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. MedRxiv, 2020. Available online at:


Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ. 2020; 369:m1432. [Crossref], [PubMed].


  • There are currently no refbacks.

Copyright (c) 2022 Research & Reviews: A Journal of Bioinformatics